Growth Metrics

Integra Lifesciences Holdings (IART) Shares Outstanding (Diluted Average) (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $76.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) changed 0.44% to $76.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $76.7 million through Dec 2025, changed 0.44% year-over-year, with the annual reading at $76.7 million for FY2025, 0.44% changed from the prior year.
  • Shares Outstanding (Diluted Average) hit $76.7 million in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $76.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $85.5 million in Q4 2021 to a low of $76.4 million in Q3 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $80.8 million across 5 years, with a median of $80.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 0.75% in 2021 and later decreased 5.57% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $85.5 million in 2021, then fell by 2.3% to $83.5 million in 2022, then dropped by 3.81% to $80.3 million in 2023, then dropped by 4.14% to $77.0 million in 2024, then decreased by 0.44% to $76.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for IART at $76.7 million in Q4 2025, $76.6 million in Q3 2025, and $76.6 million in Q2 2025.